Compound Detail
CHEMBL363317
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL363317 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | RDHQCRSDWNIXDH-UHFFFAOYSA-N |
2
Targets
5
Activities
2
Assay Types
0
PK Parameters
7
Publications
0
Known Names
Molecular Properties
312.3
MW (Da)
2.80
ALogP
6
HBA
2
HBD
97.0
PSA (Ų)
0.56
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 4.98
EC50 1 meas. best 4.96
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| KB | IC50 | = | 10500.0 | nM | 4.98 | Inhibitory activity against KB cell line after 72 h of drug exposure | 15481991 |
| KB | IC50 | = | 10500.0 | nM | 4.98 | Cytotoxicity against human KB cells after 3 days | 18722769 |
| KB 3-1 | EC50 | = | 11000.0 | nM | 4.96 | Concentration that causes 50% of maximum vinblastine accumulation in KB/MDR cell... | 15481991 |
| KB 3-1 | IC50 | = | 61600.0 | nM | 4.21 | Inhibitory activity against KB/MDR cell line after 72 hr of drug exposure | 15481991 |
| KB | IC50 | = | 61600.0 | nM | 4.21 | Cytotoxicity against multi-drug resistant human KB cells overexpressing mdr1 aft... | 18722769 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 18722769 | 10.1016/j.bmcl.2008.08.001 | Unchecked | 4 |
| 18722769 | 10.1016/j.bmcl.2008.08.001 | Transcription factor Jun | 4 |
| 18722769 | 10.1016/j.bmcl.2008.08.001 | Cyclic AMP-responsive element-binding protein 1 | 4 |
| 15481991 | 10.1021/jm049949c | KB 3-1 | 3 |
| 18722769 | 10.1016/j.bmcl.2008.08.001 | KB | 2 |
| 15481991 | 10.1021/jm049949c | KB | 1 |
| 15481991 | 10.1021/jm049949c | No relevant target | 1 |
Data from ChEMBL 36 via Core Engine